Search Results - Keertan Dheda

Keertan Dheda

Keertan Dheda Keertan Dheda MBBCh (Wits), FCP(SA), FCCP, PhD (Lond), FRCP (Lond), born in 1969, is a Professor of Mycobacteriology and Global health at the London School of Hygiene and Tropical Medicine (LSHTM) with an extra-mural joint appointment at the University of Cape Town (UCT), where he is a Professor of Respiratory Medicine.

He is a global research leader in the field of TB immunopathogenesis and TB diagnosis (Google h-index of 100 and Scopus h-Index of 79 []. Provided by Wikipedia
  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review.

    Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. by Richard N van Zyl-Smit, Alice Zwerling, Keertan Dheda, Madhukar Pai

    Published 2009-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study

    VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study by Aliasgar Esmail, Jeremi Swanepoel, Suzette Oelofse, Brandon Reyneke, Anil Pooran, Shameem Jaumdally, Lara Wiese, Keertan Dheda

    Published 2025-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review.

    Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. by Nitika Pant Pai, Jigyasa Sharma, Sushmita Shivkumar, Sabrina Pillay, Caroline Vadnais, Lawrence Joseph, Keertan Dheda, Rosanna W Peeling

    Published 2013-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.

    Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. by Matthew Arentz, Patricia Pavlinac, Michael E Kimerling, David J Horne, Dennis Falzon, Holger J Schünemann, Sarah Royce, Keertan Dheda, Judd L Walson, ART study group

    Published 2012-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: